A Clinical Trial of TQB3117 Tablets in Patients With Advanced Malignant Cancer
NCT06415903
·
clinicaltrials.gov ↗
PHASE1
Phase
NOT_YET_RECRUITING
Status
59
Enrollment
INDUSTRY
Sponsor class
Conditions
Advanced Malignant Cancer
Interventions
DRUG:
TQB3117 tablets
Sponsor
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.